RPS warns of deadly DNP on BBC Wales News
Welsh Pharmacy Board member Sudhir Sehrawat has warned about the dangers of taking so-called‘diet drug’ DNP in order to lose weight. DNP is used in industry for a variety of purposes an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 30, 2018 Category: Drugs & Pharmacology Source Type: news

Factors Impacting Diabetes Risk in HIV-infected Patients Factors Impacting Diabetes Risk in HIV-infected Patients
Is there an association between chronic hepatitis C and incidence of diabetes mellitus? What role might factors such as cirrhosis, duration of infection, and chronic hepatitis B infection play?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

New pain drugs may lower overdose and addiction risk
(Source: ScienceNOW)
Source: ScienceNOW - August 30, 2018 Category: Science Authors: Service, R. F. Tags: Biochemistry, Medicine, Diseases, Pharmacology, Toxicology In Depth Source Type: news

FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 29, 2018 Category: Drugs & Pharmacology Source Type: news

Can a New Radiopharmaceutical Company Unlock the Power of PET?
Since its invention and development in the 1970s, positron emission tomography (PET) has made an undeniable impact on cancer, neurology, and cardiology diagnosis. But the full potential of PET has been limited, primarily by cost and because the imaging technique relies on the use of radioactive isotopes to visualize physiological processes of the body and these isotopes tend to have short half-lives. Now, a new company based in Pasadena, CA, is trying to unlock the full power of PET with its radiolabeling platform that launched today. Fuzionaire Dx's technology is based on a breakthrough...
Source: MDDI - August 28, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

New Developments in Ovarian Cancer Treatment Are Showing Promise
Cancer is never an easy foe, but some types are more stubborn than others. Ovarian cancer is one of the hardest to treat. But there are signs of progress. Several recent studies have used new combination treatment strategies, including a drug that may make chemotherapy more effective and a drug originally designed to treat breast cancer. More research is needed, but the new studies provide hope for improving outcomes for women with advanced ovarian cancer, when there was little before. On its face, ovarian cancer isn’t actually more difficult to treat than other cancers like breast, prostate or lung. It is, technical...
Source: TIME: Health - August 28, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Innovation Health Source Type: news

Olaparib (LYNPARZA ®) Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Scotland to move premises in 2019
The Royal Pharmaceutical Society (RPS) has bought a property at 44 Melville Street in central Edinburgh that will become its new permanent home in Scotland from late 2019. Paul Bennett, RPS Chief Exe (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Pentothal (Thiopental Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Torecan (Thiethylperazine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Mintezol (Thiabendazole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Actisite (Tetracycline Periodontal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news

Effects of Biologics on Biliary Inflammation in PSC and IBD Effects of Biologics on Biliary Inflammation in PSC and IBD
Are the biological therapies used for the treatment of inflammatory bowel disease effective for the treatment of primary sclerosing cholangitis in patients with concomitant IBD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 28, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain
Pain-sensing sensory neurons of the dorsal root ganglion (DRG) can become sensitized or hyperexcitable in response to surgically induced peripheral tissue injury. We investigated the potential role and molecular mechanisms of nociceptive ion channel dysregulation in acute pain conditions such as those resulting from skin and soft tissue incision. We used selective pharmacology, electrophysiology, and mouse genetics to link increased current densities arising from the CaV3.2 isoform of T-type calcium channels (T-channels) to nociceptive sensitization using a clinically relevant rodent model of skin and deep tissue incision....
Source: Signal Transduction Knowledge Environment - August 28, 2018 Category: Science Authors: Joksimovic, S. L., Joksimovic, S. M., Tesic, V., Garcia-Caballero, A., Feseha, S., Zamponi, G. W., Jevtovic-Todorovic, V., Todorovic, S. M. Tags: STKE Research Articles Source Type: news

Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

Addyi (Flibanserin Tablets, for Oral Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenstr öm’s Macroglobulinemia
HORSHAM, Pa., August 27, 2018 – The Janssen Pharmaceutical Companies of Johnson& Johnson today announced the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with rituximab for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

Akcea and Ionis Receive Complete Response Letter for Waylivra from FDA
CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced that they received a Complete... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 27, 2018 Category: Drugs & Pharmacology Source Type: news

Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne
LAVAL, Quebec, Aug. 24, 2018 /PRNewswire/ -- Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world and a division of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that the U.S. Food and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 24, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Takhzyro (lanadelumab-flyo) for Hereditary Angioedema
August 23, 2018 -- The U.S. Food and Drug Administration today approved Takhzyro (lanadelumab), the first monoclonal antibody approved in the U.S. to treat patients 12 years and older with types I and II hereditary angioedema (HAE). HAE is a rare... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Inveltys (loteprednol etabonate) for Post-Operative Inflammation and Pain Following Ocular Surgery
WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 23, 2018-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Scopolamine Transdermal System (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England comments on outcome of appeal of judicial review
Commenting on the decision by the Court of Appeal touphold the High Court ruling that the reduction in funding imposed on community pharmacies in October 2016 was not unlawful, RPS England Chair Sandr (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Company led recall: Nutriflex Lipid Special without Electrolytes 2500ml
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for specific batches of Nutriflex Lipid Special without Electrolytes 2500ml as it's been identified t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Summary Care Record survey
Now that 98% of pharmacists have access to the SCR, we want to find out more about how you use it. We are updating our quick reference guide on Summary Care Records. We will be including a section (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Restoril (Temazepam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 23, 2018 Category: Drugs & Pharmacology Source Type: news

Recurrence of HCC Following Direct-acting Antiviral Therapy Recurrence of HCC Following Direct-acting Antiviral Therapy
Might direct-acting antivirals increase risk and aggressiveness of hepatocellular carcinoma recurrence? This review aimed to characterize HCC recurrence patterns after DAA therapy.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis
August 22, 2018 -- The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to BBC1 Reporting Scotland about Brexit supply chain issues
RPSspokesperson Aileen Brysonfeatured in BBC 1’s Reporting Scotland on contingency planning for the medicines supply chain by the NHS in Scotland in the event of a no-deal Brexit. Aileen expres (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

RPS backs development of pharmacist independent prescribers
The way health services are delivered is changing and there are more opportunities than ever before for Pharmacist Independent Prescribers (PIPs). Greater use of PIPs will increase patient access to (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to BBC1 and STV about Brexit supply chain issues
RPSspokesperson Aileen Brysonfeatured in BBC 1’s Reporting Scotland on contingency planning for the medicines supply chain by the NHS in Scotland in the event of a no-deal Brexit. Aileen expres (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

Perseris (Risperidone) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

Cequa (Cyclosporine Ophthalmic Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

Galafold (Migalastat Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

RPS backs development of pharmacist independent prescribers
The way health services are delivered is changing and there are more opportunities than ever before for Pharmacist Independent Prescribers (PIPs). Greater use of PIPs will increase patient access to (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

Mallinckrodt Confirms Receipt of Stannsoporfin Complete Response Letter
STAINES-UPON-THAMES, United Kingdom, Aug. 22, 2018 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, confirmed today that it has received a Complete Response Letter from the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Diacomit (stiripentol) for Seizures Associated with Dravet Syndrome
On August 20, 2018, the U.S. Food and Drug Administration (FDA) approved Diacomit (stiripentol) for seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam. Dravet syndrome is a rare genetic condition that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for Ulipristal Acetate New Drug Application
DUBLIN, Aug. 21, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for ulipristal acetate (UPA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Solodyn (Minocycline Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Benzodiazepines vs. Ambien
Title: Benzodiazepines vs. AmbienCategory: MedicationsCreated: 8/21/2018 12:00:00 AMLast Editorial Review: 8/21/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Tong-Xie-Yao-Fang vs Placebo for Diarrhea-Predominant IBS Tong-Xie-Yao-Fang vs Placebo for Diarrhea-Predominant IBS
Might the Chinese herbal formula Tong-Xie-Yao-Fang be effective in controlling symptoms of IBS-D?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Expanded Label for Merck ’s Keytruda (pembrolizumab) in Patients with Metastatic Nonsquamous NSCLC with No EGFR or ALK Genomic Tumor Aberrations
KENILWORTH, N.J.--(BUSINESS WIRE) August 20, 2018 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck ’s... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Prednisolone Acetate 1% Ophthalmic Suspension (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 20, 2018 Category: Drugs & Pharmacology Source Type: news